Delenex Therapeutics Ag

Calculating rank

USPTO Granted Patents = 5

% Expired Patents = 80.0

CIPO Patents = 1

EPO Patents = 3

Forward Citations = 11

Loading Chart...

11 inventors (with patents filed for the assignee):

Adrian Auf Der Maur (4 out of 17 patents)

Roger Nitsch (2 out of 28 patents)

Alcide Barberis (2 out of 22 patents)

4. Peter Lichtlen (2 out of 9 patents)

5. Stefan Ewert (2 out of 15 patents)

6. Susann Cattepoel (2 out of 2 patents)

7. Titus Kretzschmar (1 out of 9 patents)

8. Abdijapar Shamshiev (1 out of 9 patents)

9. Simone Schmitt (1 out of 6 patents)

10. Stefanie Grabulovski (1 out of 6 patents)

11. Thorsten Alexander Schäfer (1 out of 1 patent)

12. Annemarie Honegger (7 patents)

13. Simone Schmitt (1 patent)

5 patents: Sort by Forward Citations

1. 9404930 - Antibody to human IL-1 beta (2016-08-02),

2. 9273126 - Humanized antibodies against the beta-amyloid peptide (2016-03-01),

3. 8945563 - Method for treating glioblastoma using antibodies binding to the extracellular domain of the receptor tyrosine kinase ALK (2015-02-03),

4. 8323647 - Humanized antibodies against the β-amyloid peptide (2012-12-04),

5. 7902340 - Antibodies binding to the extracellular domain of the receptor tyrosine kinase ALK (2011-03-08),

Company Overview

Delenex Therapeutics Ag is a biopharmaceutical company dedicated to developing innovative antibody-based therapies for a wide range of diseases. With a focus on advancing precision medicine, Delenex is committed to discovering and delivering novel treatments that improve patient outcomes and quality of life. The company's cutting-edge research and development programs target areas such as oncology, immunology, and rare genetic disorders, with the goal of addressing unmet medical needs and transforming the future of healthcare.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

5 Patents

#18 in Schlieren

#1,708 in Switzerland

Schlieren, Switzerland

Delenex Therapeutics Ag

Forward Citations = 11

11 inventors:

Adrian Auf Der Maur (4 out of 17 patents)

Roger Nitsch (2 out of 28 patents)

Alcide Barberis (2 out of 22 patents)

4. Peter Lichtlen (2 out of 9 patents)

5. Stefan Ewert (2 out of 15 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Delenex Therapeutics Ag. Retrieved from https://idiyas.com/company/delenex-therapeutics-ag

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

3 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]